Sam Gandy MD PhD

Globalizing ancestral diversity in AD genetics is essential to identify interventions across populations. Learn about critical efforts to address this need in this #TRCI article🧵 alz-journals.onlinelibrary.wiley.com/doi/10.1002/tr…

NewAmsterdam links lipid-lowering drug to improvement in Alzheimer's cognition biomarker fiercebiotech.com/biotech/newams…

Please re-Tweet to help raise awareness that not all #dementia is Alzheimer's disease. There are 100+ different types of dementia, including #Alzheimers. Learn more: alzheimers.gov/alzheimers-dem… (image: @KateSwaffer)

Watch Donna Wilcock’s @Wilcock_v2 insights on Forum 3: Improving the Therapeutic Potential of Immunotherapies in AD - Can Novel Strategies or Next Generation Drugs Halt or Further Delay Desease Progression? #ADPD2025